GAD‐M REGIMEN FOR NEWLY DIAGNOSED EXTRANODAL NK/T CELL LYMPHOMA: ANALYSIS OF EFFICACY AND SAFETY FROM PHASE II STUDY (NCT 01991158). (June 2017) - Wang, Y.; Gao, T.; Liu, Z.; Xia, Y.; Liu, P.; Sun, P.; Bi, X.; Yang, H.; Jiang, W.; Li, Z.